Live data · NADAC + Part D CY24 · reviewed daily

Fluorometholone (FML)

Corticosteroid class · 2 generic manufacturers · 2 ANDAs filed at FDA.

First FDA approval1972-02-01
Generic availableYes · 2 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$51.2M in CY2024 Part D spend646K claims · 351K beneficiaries · 329 plans surveyed

Lowest NADAC
$11.43/unit
8 NDCs benchmarked, lowest of all strengths.
Average NADAC
$20.80
Across all dosage forms in distribution.
Highest NADAC
$32.19
Range is tight.
Plans with PA
0 / 329
Zero PA friction across surveyed plans.

Questions a plan sponsor actually asks.

FAQPage schema11 entries indexed · 4 visible
What is Fluorometholone used for?

Fluorometholone is tracked in Medicare Part D. Specific indication information is not available in our current dataset.

Is there a generic for Fluorometholone?

Yes. 2 ANDAs filed at FDA, 2 generic manufacturers currently shipping.

How much does my plan pay for Fluorometholone?

Across 329 Part D plans, Fluorometholone averages $20.80/unit (NADAC). Lowest available: $11.43/unit. Highest in distribution: $32.19/unit.

Is Fluorometholone on the FDA shortage list?

No. Fluorometholone is not currently on the FDA Drug Shortage Database.

7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Sources · every number above traces back.

Last refresh15 Oct 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (5 approvals on file) · NADAC unit costs: CMS NADAC weekly file (8 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.